Tourmaline Bio shares are trading higher after a Friday filing showed Pfizer reported a 6.29% stake in the company.
Tourmaline Bio, Inc. - Common Stock +3.23% Pre
Tourmaline Bio, Inc. - Common Stock TRML | 27.45 27.45 | +3.23% 0.00% Pre |
Tourmaline Bio shares are trading higher after a Friday filing showed Pfizer reported a 6.29% stake in the company.